Company Profile
Lupin is a pharmaceutical company globally. The company operates in two segments: Pharmaceuticals and Others. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutical ingredients (APIs) formulations for use in the therapeutic areas of anti-tuberculosis, diabetes management, cardiovascular, chronic obstructive pulmonary diseases, asthma, women's health, and central nervous system areas
Pediatrics, gastrointestinal, anti-infective, and nonsteroidal anti-inflammatory drug therapies. Additionally, it focuses on various therapeutic spectrum, including rheumatology, oncology, neuroscience, and renal therapies, as well as diagnostics services, and digital healthcare services neuro rehabilition business.
Its business is organized into network consists of labs and collection centers. The company has a strategic collaboration with TB Alliance for the development and commercialization of the investigational drug Telacebec for the treatment of multiple mycobacterial diseases including tuberculosis (TB), leprosy, and buruli ulcer. Founded in 1968 and headquartered in Mumbai, India, Lupin was formerly known as Lupin Chemicals Limited before rebranding in 2001.